Researchers develop peptide that can target tumors, deliver agents

10/27/2009 | EurekAlert!

Two University of Rhode Island researchers have developed a peptide called pHLIP that was able to locate a tumor in a mouse then deliver imaging and therapeutic agents to the cancer cells without harming surrounding healthy cells. The peptide's delivery method involves the use of a molecular nanosyringe that can deliver nanogold particles directly to the cancerous tumors. The technology has a pending patent in the U.S. and Europe.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID